Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001171843-17-002930
Filing Date
2017-05-10
Accepted
2017-05-10 16:45:34
Documents
4

Document Format Files

Seq Description Document Type Size
1 FORM S-3 s3_051017.htm S-3 150724
2 EXHIBIT 5.1 exh_51.htm EX-5.1 10442
3 EXHIBIT 23.1 exh_231.htm EX-23.1 1790
4 GRAPHIC logo.jpg GRAPHIC 30623
  Complete submission text file 0001171843-17-002930.txt   206207
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-217859 | Film No.: 17831125
SIC: 2836 Biological Products, (No Diagnostic Substances)